Results 81 to 90 of about 530 (160)

Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients. [PDF]

Eur J Health Econ
Diop M, Perrier L, Haon B, Rochaix L, Behaghel L, Dupont JK, Morelle M, Elias M, Esposito L, Legendre C, Longuet H, Durand-Zaleski I, Pillebout E, PIC-R trial Investigators.   +13 more
europepmc   +1 more source

Better beans: designer TALE-mediated discovery of common bacterial blight resistance. [PDF]

J Exp Bot
Karki SJ.
europepmc   +1 more source

Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024. [PDF]

Euro Surveill
Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, Thomas N, Gbaguidi G, Mercier A, Prudhomme J, Visseaux B, Vieillefond V, Haim-Boukobza S, Giannoli JM, RELAB Study Group, Laboratory group, Castro-Alvarez J, Kouamen AC, Rameix-Welti MA, Beirrera-Ibraim S, Destras G, Josset L, Cauchemez S, Lina B, Coignard B, Schaeffer J, Enouf V, Bal A, Members of the Laboratory Group, Members of the RELAB Study Group.   +29 more
europepmc   +1 more source

Em homenagem a Jacques Le Goff

, 2004
Metacrítica : Revista de Filosofia da Unidade de Investigação em Ciência, Tecnologia e Sociedade da Universidade ...
openaire   +1 more source

Comprehensive Catalog of Variants Potentially Associated with Hidradenitis Suppurativa, Including Newly Identified Variants from a Cohort of 100 Patients. [PDF]

Int J Mol Sci
Muret K, Le Goff V, Dandine-Roulland C, Hotz C, Jean-Louis F, Boisson B, Mesrob L, Sandron F, Daian D, Olaso R, Le Floch E, Meyer V, Wolkenstein P, Casanova JL, Lévy Y, Bonnet E, Deleuze JF, Hüe S.   +17 more
europepmc   +1 more source

The Question of the Narrative in Historiography: Between the Annales School and Hayden White. [PDF]

Open Res Eur
Držaić K.
europepmc   +1 more source

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study. [PDF]

Ann Hematol
Dartigeas C, Quinquenel A, Ysebaert L, Dilhuydy MS, Anglaret B, Slama B, Le Du K, Tardy S, Tchernonog E, Orfeuvre H, Voillat L, Guidez S, Malfuson JV, Dupuis S, Deslandes M, Feugier P, Leblond V, FIRE Investigators Group.   +17 more
europepmc   +1 more source

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials. [PDF]

EClinicalMedicine
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Group.   +16 more
europepmc   +1 more source

The association between the type of bystander and survival after an out-of-hospital cardiac arrest: A French nationwide study. [PDF]

Resusc Plus
Benkerrou H, Lockhart M, Heidet M, Azzouz R, Vilhelm C, Hubert H, Recher M, Baert V, GR-RéACb.   +8 more
europepmc   +1 more source

Synteruptor: mining genomic islands for non-classical specialized metabolite gene clusters. [PDF]

NAR Genom Bioinform
Haas D, Barba M, Vicente CM, Nezbedová Š, Garénaux A, Bury-Moné S, Lorenzi JN, Hôtel L, Laureti L, Thibessard A, Le Goff G, Ouazzani J, Leblond P, Aigle B, Pernodet JL, Lespinet O, Lautru S.   +16 more
europepmc   +1 more source